Mitochondrial dysfunction and activation of iNOS are responsible for the palmitate-induced decrease in adiponectin...

Area of Science:

• Cell Biology
• Metabolic Disease Research
• Molecular Endocrinology

Background:

• Mitochondrial dysfunction and endoplasmic reticulum (ER) stress are key drivers of insulin resistance.
• Impaired mitochondrial function in obesity can lead to ER stress and reduced adiponectin synthesis in adipocytes.
• Increased inducible nitric oxide synthase (iNOS) expression is observed in adipose tissue during obesity.

Purpose of the Study:

• To investigate if inducible nitric oxide synthase (iNOS) activation mediates palmitate-induced mitochondrial dysfunction, ER stress, and decreased adiponectin synthesis in 3T3L1 adipocytes.
• To elucidate the causal relationship between mitochondrial dysfunction, iNOS activation, ER stress, and adiponectin regulation in adipocytes.

Main Methods:

• Utilized 3T3L1 adipocytes treated with palmitate.
• Administered iNOS inhibitors and agents affecting mitochondrial function or biogenesis.
• Assessed iNOS expression, ER stress markers, mitochondrial content, and adiponectin synthesis.

Main Results:

• Palmitate increased iNOS expression, ER stress markers, and decreased mitochondrial content.
• iNOS inhibition reversed ER stress and increased adiponectin synthesis but did not affect mitochondrial content.
• Mitochondrial dysfunction induced iNOS expression and ER stress; enhanced mitochondrial biogenesis reversed these effects.

Conclusions:

• Palmitate-induced mitochondrial dysfunction is the primary event initiating iNOS induction, ER stress, and reduced adiponectin synthesis in adipocytes.
• iNOS activation contributes to ER stress and adiponectin reduction but is not the cause of mitochondrial dysfunction.
• Targeting mitochondrial biogenesis may offer therapeutic strategies for obesity-related metabolic dysfunction.